Acute Antibody-mediated Rejection 1 Week After Lung Transplantation Successfully Treated With Eculizumab, Intravenous Immunoglobulins, and Rituximab.

Détails

Ressource 1Télécharger: 29521880_pp_cover.pdf (493.82 [Ko])
Etat: Public
Version: Author's accepted manuscript
ID Serval
serval:BIB_A55614976F55
Type
Article: article d'un périodique ou d'un magazine.
Collection
Publications
Titre
Acute Antibody-mediated Rejection 1 Week After Lung Transplantation Successfully Treated With Eculizumab, Intravenous Immunoglobulins, and Rituximab.
Périodique
Transplantation
Auteur(s)
Muller Y.D., Aubert J.D., Vionnet J., Rotman S., Sadallah S., Aubert V., Pascual M.
ISSN
1534-6080 (Electronic)
ISSN-L
0041-1337
Statut éditorial
Publié
Date de publication
06/2018
Peer-reviewed
Oui
Volume
102
Numéro
6
Pages
e301-e303
Langue
anglais
Notes
Publication types: Case Reports ; Letter ; Research Support, Non-U.S. Gov't
Publication Status: ppublish
Mots-clé
Antibodies, Monoclonal, Humanized/therapeutic use, Drug Therapy, Combination, Female, Graft Rejection/diagnosis, Graft Rejection/drug therapy, Graft Rejection/immunology, Graft Survival/drug effects, Humans, Immunoglobulins, Intravenous/therapeutic use, Immunosuppressive Agents/therapeutic use, Isoantibodies/immunology, Lung Transplantation/adverse effects, Middle Aged, Rituximab/therapeutic use, Time Factors, Treatment Outcome
Pubmed
Web of science
Création de la notice
13/03/2018 9:34
Dernière modification de la notice
20/08/2019 15:10
Données d'usage